Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0001193125-26-064261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-20 | CGEM | Fenton Mary Kay | CFO | S - Sale | $13.62 | -4,398 | 126.4K | -3% | -$59.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | S | D | 4,398 | $13.62 | 126,380 | D | — | — |